: Guardant Health stock falls after secondary offering announced


Guardant Health Inc. GH, +2.46% shares fell in the extended session Monday after the cancer testing company announced a secondary offering of its stock. Guardant shares fell as much as 8% after hours, following a 2.5% rise to close the regular session at $30.80. The company said it plans to sell $250 million in shares with a 30-day option for an additional $37.5 million to cover overallotments. Underwriters include JP Morgan, Goldman Sachs, TD Cowen, and SVB Securities. 

This article was originally published by Marketwatch.com. Read the original article here.

Previous articleThe Moneyist: ‘I risk being labeled a tightwad:’ Is it OK for restaurants to automatically add a 20% tip? Shouldn’t tipping be optional? 
Next article: ‘The momentum in the housing market has shifted to the Sun Belt’: 5 hottest metros are in the South


Please enter your comment!
Please enter your name here